Stocks
The Chemours Company (CC) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.15 | 2.32 | 15.7 | 5.26 | 11.8 | 22.5 | |||
| Changes by years, y/y, % | -48% | +8% | +576% | -67% | +124% | +23.3% | |||
The Chemours Company. Debt/EBITDA
The Chemours Company. Debt/EBITDA, changes, %
The Chemours Company (CC) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| Debt/EBITDA | 9.72 | 24.3 | 29.0 | 91.7 | -20.8 | 22.5 | ||
| Changes by years, y/y, % | +83% | +353% | +366% | +628% | -265% | |||
| Changes by quarters, q/q, % | -23% | +150% | +19% | +216% | -123% | |||
